8-KEarnings & ResultsFinancial Events

DEXCOM INC 8-K Report, Financial Results (Feb 21, 2019)

Filed February 21, 2019For Securities:DXCM

Summary

DexCom, Inc. (DXCM) filed an 8-K on February 21, 2019, primarily reporting its fourth quarter and full-year 2018 financial results via an attached press release. While specific financial figures from the press release are not detailed in the 8-K text itself, this filing indicates that these results are being communicated to investors. In addition to financial results, the filing discloses a significant strategic decision by DexCom's Board of Directors on February 20, 2019, to implement a restructuring plan. This plan involves transitioning certain operations to the Philippines, aiming to reduce operating expenses, enhance cost competitiveness, and improve scalability. The restructuring is expected to impact approximately 350 employees, representing about 13% of the total workforce, and incur pre-tax charges estimated at $25 million, primarily in the first half of 2019.

Key Highlights

  • 1DexCom announced its financial results for the quarter and year ended December 31, 2018.
  • 2A press release containing the detailed financial results for the period was furnished as an exhibit.
  • 3DexCom's Board of Directors approved a restructuring plan on February 20, 2019.
  • 4The restructuring involves transitioning certain operations to the Philippines.
  • 5The plan aims to reduce operating expenses and improve cost competitiveness and scalability.
  • 6Approximately 350 employees (13% of the workforce) are expected to be impacted.
  • 7Estimated pre-tax charges of $25 million are anticipated for this restructuring, primarily in the first half of 2019.

Frequently Asked Questions

This 8-K filing primarily serves to announce DexCom's fourth quarter and full-year 2018 financial results through an attached press release. While the specific financial metrics (like revenue, net income, etc.) are detailed in the press release itself and not within the 8-K text, investors should refer to Exhibit 99.01 for those details.

The Restructuring involves transitioning certain DexCom operations to the Philippines. The company is doing this to reduce operating expenses, improve cost competitiveness, and increase the scalability of specific business functions.

DexCom estimates incurring pre-tax charges and costs of approximately $25 million related to the Restructuring. These costs are primarily expected to be cash-based, including severance and termination benefits, and are anticipated to be incurred mostly in the first half of 2019.

The Restructuring is expected to impact approximately 350 full-time employees, which represents about 13% of DexCom's total workforce as of December 31, 2018. The majority of these employees are located in San Diego, California, and Mesa, Arizona.